Open Veils · Answer
Dr pierre kory chlorine dioxide
Dr. Pierre Kory argues chlorine dioxide is not bleach but a selective oxidizing agent with a distinct chemistry, suppressed primarily because it is cheap, non-patentable, and broadly effective. His book 'The War on Chlorine Dioxide' frames the molecule's marginalization as a replay of the ivermectin suppression — inconvenient therapies reduced to a dismissive label so the underlying data never gets examined. The pattern, Kory contends, is structural: the Rockefeller pharmaceutical model cannot monetize a compound anyone can prepare at low cost.
Evidence
- Kory's central chemical argument is that chlorine dioxide is not sodium hypochlorite (household bleach) but a selective oxidizing agent operating through redox electron-transfer mechanisms.
- Kory situates chlorine dioxide within a broader family of oxidative therapies — ozone, methylene blue, hydrogen peroxide, ultraviolet blood irradiation — but singles it out for one practical advantage: viable oral administration.
- The political endorsement of Senator Ron Johnson (ProPublica, Dec 2025) predictably reignited institutional pushback, framing the book as dangerous misinformation.
- In his telling, its weakness is its therapeutic virtue: the compound is too mild to overwhelm the antioxidant defenses of healthy host tissue and normal microbiome flora, yet potent enough to breach the comparatively weaker defenses of pathogens.
- This selectivity, he argues, makes it categorically unlike broad oxidative agents.